Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

New alopecia treatments aim for better results and fewer side effects.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

PPARα agonists may help treat alopecia areata by reducing inflammation.

The document concludes that scalp conditions have various causes and can present in many different ways.

Topical treatments helped a child with Down syndrome and severe hair loss regrow most of his hair.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Aromatic plants can naturally help prevent skin aging and improve skin health.

The guidelines offer updated treatment recommendations for alopecia areata in Korea using topical and device-based methods.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Baricitinib is more effective than methotrexate for severe alopecia areata.

A combined treatment with microneedling and vitamin D3 led to complete hair regrowth in a woman with stubborn patch alopecia areata.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Finasteride helps female-pattern hair loss.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Improved delivery methods can enhance mangiferin's effectiveness as a health supplement.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.